HQ Equita exits Windstar Medical in trade sale
German private equity firm HQ Equita has sold Wehrheim-based drugs maker Windstar Medical to trade buyer 7Life.
The acquiring party is the subsidiary of German media conglomerate ProSiebenSat.1 Group and will buy HQ Equita's majority shareholding in Windstar.
For HQ, the exit comes less than two years after it acquired its majority stake in the company via an MBO in December 2014.
Previous funding
HQ Equita completed the buyout of Windstar in December 2014 in a deal valued between €50-100m.
The following year, Equita completed a refinancing round of the company, led by Berenberg Bank, Sparkasse and BHF Bank.
Company
Founded in 1993, Windstar is a Wehrheim-based producer of non-prescription drugs and health products.
The company's products are sold in non-pharmacy outlets such as supermarkets. Its operations also include redesigning prescription drugs for the generic market.
People
Windstar Medical – Thomas Weiss (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









